Home›Companies›Healthcare›Magnendo

Magnendo Corp.

Develops robotic guidewires to help physicians reach blood vessels in the brain.

Updated Nov 10, 2026·Latest SEC filing Jul 29, 2026·Suggest an edit

About Magnendo

Magnendo is a private company based in Newton, Massachusetts, incorporated in 2024 in Delaware. It has reported $20,254,999 raised in two offerings on Form D since June 2024. Its chief executive is Yoonho Kim.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Jul 17, 2026Jul 29, 2026$18,000,000fully sold10$1.8MEquityRule 506(b)Form D ↗
Jun 5, 2024Jun 20, 2024amended Oct 23, 2024$2,254,999of $3.5M target37$60,946Securities on exercise, Convertible DebtRule 506(b)Form D/A ↗1 earlier filing
Total, two offerings$20,254,999

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Magnendo's Form D filed Jul 29, 2026.

YK
Yoonho Kim
President & CEO, director
Aman Patel
Aman Patel
Chief Clinical Advisor and director
Xuanhe Zhao
Xuanhe Zhao
Scientific Advisor and director
Jeffrey Arnold
Jeffrey Arnold
Executive Chairman

Earlier filings also listed Meir Rosenberg (chief development officer, last listed Oct 2024).

Sources

  1. SECMagnendo Corp. Form D, filed Jun 20, 2024
  2. SECMagnendo Corp. filing history